Idiopathic Pulmonary Fibrosis (IPF) is a chronic, progressive, irreversible, unpredictable and incurable disease that kills the same number of people every year as breast cancer. Yet, IPF remains an unknown disease that receives little attention resulting in a lack of innovative solutions, research, patient resources, and funding that is desperately needed. But with Three Lakes Partners, all that changes now.
Collaboration is at the heart of Three Lakes Partner’s mission, and is our engine. We want problem solvers, innovative thinkers and people with a passion. Together we will find, create and fund the science and technology needed to accelerate progress in this largely ignored disease. Learn more about the IPF Catalyst Challenge.